US Stock MarketDetailed Quotes

DYN Dyne Therapeutics

Watchlist
  • 26.080
  • +0.080+0.31%
Close May 3 16:00 ET
  • 26.080
  • 0.0000.00%
Post 16:04 ET
2.28BMarket Cap-6552P/E (TTM)

Dyne Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
52.11%69.16M
41.65%242.16M
68.61%67.69M
47.29%62.27M
26.50%66.74M
27.05%45.46M
13.96%170.96M
-22.74%40.15M
-1.14%42.28M
74.89%52.76M
Selling and administrative expenses
210.52%24.62M
11.34%31.4M
27.16%8.84M
-7.71%7.02M
24.87%7.61M
5.05%7.93M
-1.79%28.2M
-27.99%6.96M
21.63%7.61M
-3.21%6.09M
-General and administrative expense
210.52%24.62M
11.34%31.4M
27.16%8.84M
-7.71%7.02M
24.87%7.61M
5.05%7.93M
-1.79%28.2M
-27.99%6.96M
21.63%7.61M
-3.21%6.09M
Research and development costs
18.66%44.54M
47.63%210.76M
77.29%58.84M
59.36%55.25M
26.71%59.13M
32.94%37.54M
17.68%142.76M
-21.54%33.19M
-5.04%34.67M
95.48%46.66M
Operating profit
-52.11%-69.16M
-41.65%-242.16M
-68.61%-67.69M
-47.29%-62.27M
-26.50%-66.74M
-27.05%-45.46M
-13.96%-170.96M
22.74%-40.15M
1.14%-42.28M
-74.89%-52.76M
Net non-operating interest income expense
101.07%3M
161.95%7.64M
30.48%1.75M
142.41%2.19M
400.45%2.21M
549.13%1.49M
293.13%2.92M
637.36%1.34M
390.76%903K
110.00%441K
Non-operating interest income
101.07%3M
161.95%7.64M
30.48%1.75M
142.41%2.19M
400.45%2.21M
549.13%1.49M
293.13%2.92M
637.36%1.34M
390.76%903K
110.00%441K
Other net income (expense)
334.26%506K
-2,522.22%-1.42M
-2,820.83%-701K
-1,300.00%-126K
-3,830.00%-373K
-620.00%-216K
-575.00%-54K
-24K
-9K
10K
Other non- operating income (expenses)
334.26%506K
-2,522.22%-1.42M
-2,820.83%-701K
-1,300.00%-126K
-3,830.00%-373K
-620.00%-216K
-575.00%-54K
---24K
---9K
--10K
Income before tax
-48.57%-65.65M
-40.36%-235.94M
-71.63%-66.64M
-45.49%-60.21M
-24.09%-64.9M
-24.18%-44.19M
-12.60%-168.1M
25.02%-38.83M
2.81%-41.39M
-74.61%-52.3M
Income tax
Net income
-48.57%-65.65M
-40.36%-235.94M
-71.63%-66.64M
-45.49%-60.21M
-24.09%-64.9M
-24.18%-44.19M
-12.60%-168.1M
25.02%-38.83M
2.81%-41.39M
-74.61%-52.3M
Net income continuous Operations
-48.57%-65.65M
-40.36%-235.94M
-71.63%-66.64M
-45.49%-60.21M
-24.09%-64.9M
-24.18%-44.19M
-12.60%-168.1M
25.02%-38.83M
2.81%-41.39M
-74.61%-52.3M
Minority interest income
Net income attributable to the parent company
-48.57%-65.65M
-40.36%-235.94M
-71.63%-66.64M
-45.49%-60.21M
-24.09%-64.9M
-24.18%-44.19M
-12.60%-168.1M
25.02%-38.83M
2.81%-41.39M
-74.61%-52.3M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-48.57%-65.65M
-40.36%-235.94M
-71.63%-66.64M
-45.49%-60.21M
-24.09%-64.9M
-24.18%-44.19M
-12.60%-168.1M
25.02%-38.83M
2.81%-41.39M
-74.61%-52.3M
Basic earnings per share
-3.85%-0.81
-22.29%-3.95
-47.30%-1.09
-23.75%-0.99
-6.93%-1.08
-13.04%-0.78
-10.24%-3.23
26.00%-0.74
3.61%-0.8
-74.14%-1.01
Diluted earnings per share
-3.85%-0.81
-22.29%-3.95
-47.30%-1.09
-23.75%-0.99
-6.93%-1.08
-13.04%-0.78
-10.24%-3.23
26.00%-0.74
3.61%-0.8
-74.14%-1.01
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 52.11%69.16M41.65%242.16M68.61%67.69M47.29%62.27M26.50%66.74M27.05%45.46M13.96%170.96M-22.74%40.15M-1.14%42.28M74.89%52.76M
Selling and administrative expenses 210.52%24.62M11.34%31.4M27.16%8.84M-7.71%7.02M24.87%7.61M5.05%7.93M-1.79%28.2M-27.99%6.96M21.63%7.61M-3.21%6.09M
-General and administrative expense 210.52%24.62M11.34%31.4M27.16%8.84M-7.71%7.02M24.87%7.61M5.05%7.93M-1.79%28.2M-27.99%6.96M21.63%7.61M-3.21%6.09M
Research and development costs 18.66%44.54M47.63%210.76M77.29%58.84M59.36%55.25M26.71%59.13M32.94%37.54M17.68%142.76M-21.54%33.19M-5.04%34.67M95.48%46.66M
Operating profit -52.11%-69.16M-41.65%-242.16M-68.61%-67.69M-47.29%-62.27M-26.50%-66.74M-27.05%-45.46M-13.96%-170.96M22.74%-40.15M1.14%-42.28M-74.89%-52.76M
Net non-operating interest income expense 101.07%3M161.95%7.64M30.48%1.75M142.41%2.19M400.45%2.21M549.13%1.49M293.13%2.92M637.36%1.34M390.76%903K110.00%441K
Non-operating interest income 101.07%3M161.95%7.64M30.48%1.75M142.41%2.19M400.45%2.21M549.13%1.49M293.13%2.92M637.36%1.34M390.76%903K110.00%441K
Other net income (expense) 334.26%506K-2,522.22%-1.42M-2,820.83%-701K-1,300.00%-126K-3,830.00%-373K-620.00%-216K-575.00%-54K-24K-9K10K
Other non- operating income (expenses) 334.26%506K-2,522.22%-1.42M-2,820.83%-701K-1,300.00%-126K-3,830.00%-373K-620.00%-216K-575.00%-54K---24K---9K--10K
Income before tax -48.57%-65.65M-40.36%-235.94M-71.63%-66.64M-45.49%-60.21M-24.09%-64.9M-24.18%-44.19M-12.60%-168.1M25.02%-38.83M2.81%-41.39M-74.61%-52.3M
Income tax
Net income -48.57%-65.65M-40.36%-235.94M-71.63%-66.64M-45.49%-60.21M-24.09%-64.9M-24.18%-44.19M-12.60%-168.1M25.02%-38.83M2.81%-41.39M-74.61%-52.3M
Net income continuous Operations -48.57%-65.65M-40.36%-235.94M-71.63%-66.64M-45.49%-60.21M-24.09%-64.9M-24.18%-44.19M-12.60%-168.1M25.02%-38.83M2.81%-41.39M-74.61%-52.3M
Minority interest income
Net income attributable to the parent company -48.57%-65.65M-40.36%-235.94M-71.63%-66.64M-45.49%-60.21M-24.09%-64.9M-24.18%-44.19M-12.60%-168.1M25.02%-38.83M2.81%-41.39M-74.61%-52.3M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -48.57%-65.65M-40.36%-235.94M-71.63%-66.64M-45.49%-60.21M-24.09%-64.9M-24.18%-44.19M-12.60%-168.1M25.02%-38.83M2.81%-41.39M-74.61%-52.3M
Basic earnings per share -3.85%-0.81-22.29%-3.95-47.30%-1.09-23.75%-0.99-6.93%-1.08-13.04%-0.78-10.24%-3.2326.00%-0.743.61%-0.8-74.14%-1.01
Diluted earnings per share -3.85%-0.81-22.29%-3.95-47.30%-1.09-23.75%-0.99-6.93%-1.08-13.04%-0.78-10.24%-3.2326.00%-0.743.61%-0.8-74.14%-1.01
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg